NEWTON, Mass. (AP) _ Karyopharm Therapeutics Inc. (KPTI) on Tuesday reported a loss of $46.4 million in its second quarter.

On a per-share basis, the Newton, Massachusetts-based company said it had a loss of 63 cents.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.

The pharmaceutical company posted revenue of $33.5 million in the period, exceeding Street forecasts. Six analysts surveyed by Zacks expected $28 million.

Karyopharm Therapeutics shares have dropped 12% since the beginning of the year. The stock has increased 91% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI

© 2020 The Canadian Press. All rights reserved., source Canadian Press DataFile